Photocure Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 89
Employees
  • Stock Symbol
  • PHO
Stock Symbol
  • Share Price
  • $16.14
  • (As of Monday Closing)

Photocure General Information

Description

PhotoCure ASA is a Norway-based specialty pharmaceutical company. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. The operating segments of the group are the Commercial franchise and Development portfolio. The company markets product through its commercial operation in the Nordic region under the brand name Hexvix and in the US under the brand name Cysview. It generates prime revenue from the Commercial franchise segment, which includes the Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, United Kingdom, Netherlands, Other European countries, and United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Devices and Supplies
Stock Exchange
OSL
Primary Office
  • Hoffsveien 4
  • 0275 Oslo
  • Norway
+47 22 00 00 00

Photocure Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Photocure Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.14 $16.71 $7.11 - $18.47 $434M 26.9M 119K $0.05

Photocure Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 397,887 305,078 211,324 108,517
Revenue 31,475 27,105 31,983 22,289
EBITDA 687 (1,327) 6,890 (3,032)
Net Income 1,138 (2,368) 3,616 (4,508)
Total Assets 89,669 90,906 29,180 26,536
Total Debt 3,654 6,312 788 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Photocure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Photocure‘s full profile, request access.

Request a free trial

Photocure Executive Team (7)

Name Title Board Seat Contact Info
Daniel Schneider President & Chief Executive Officer
Erik Dahl Chief Financial Officer
Grete Hogstad Vice President Strategic Marketing
You’re viewing 3 of 7 executive team members. Get the full list »

Photocure Board Members (11)

Name Representing Role Since
000000 000 Radforsk Investeringsstiftelse Board Member 000 0000
0000 0000ø0 Photocure Board Member & Member of Audit Committee 000 0000
0000000 0000 00 Self Board Member 000 0000
000 0000000 00 Self Chairman 000 0000
0000000 00000000 00 Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Photocure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Photocure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Photocure‘s full profile, request access.

Request a free trial